A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Washington D.C. — Today, U.S. Senator Marco Rubio (R-FL), Chairman of the Senate Committee on Small Business and Entrepreneurship, joined Senator Chris Coons (D-DE) in introducing the Research Advancing to Market Production (RAMP) for Innovators Act, which would improve small businesses’ ability to commercialize in the U.S. Small Business Administration’s (SBA) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The RAMP for Innovators Act would expand access to research and development awards with preference to small firms with high growth potential, improve technical and business assistance, assess small business commercialization impact, and assist firms with the intellectual property protection process.
“It is critical that we harness small business ingenuity in advanced industrial industries by boosting firms’ ability to commercialize their technology,” Rubio said. “We are in a geopolitical competition with foreign nations like China and in order to compete we must ensure that small businesses have optimal opportunities to innovate and contribute to the global economy. It is in our national interest to make policy decisions that will strengthen American innovation and increase commercialization through the SBIR and STTR programs. I appreciate working with Senator Coons on this important legislation to help high-growth firms receive the support they need as we continue our work to comprehensively reauthorize the Small Business Act.”
“Startups are vital to job creation in the United States, but those companies need support to overcome market challenges and scale up manufacturing in America,” Coons said. “This bill will help American scientists and engineers protect the intellectual property of their pioneering technologies and form new companies that grow the economy. I’m proud to work with Sen. Rubio to continue helping U.S. manufacturers across the ‘valley of death’ and into successful market production.”
Specifically, the Research Advancing to Market Production (RAMP) for Innovators Act would: